Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Med Mol Morphol
; 56(1): 38-45, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36367588
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Uterine Cervical Neoplasms
/
MicroRNAs
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Med Mol Morphol
Year:
2023
Document type:
Article